Malaria, Vivax: Clinical Trials

24 trials for Malaria, Vivax, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 recruiting, 2 not yet recruiting, 2 terminated. 24 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 424Completed 12, Recruiting 4, Not yet recruiting 2, Terminated 2, Unknown 2, Withdrawn 2

Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tafenoquine and ACTs (TADORE- Plus)
Tafenoquine plus DHA-Piperaquine, Tafenoquine plus Artesunate-pyronaridine - Vivax Malaria
Phase 4Not yet recruitingMenzies School of Health Research5072026-06-012026-03-18
Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria
Single dose tafenoquine (10 mg/kg), Dihydroartemisinin-piperaquine (DHA-PPQ), Artemether + Lumefantrine - Uncomplicated Malaria
Phase 4Not yet recruitingCurtin University602026-04-012026-02-12
Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
Single dose tafenoquine (10 mg/kg) given with water, Single dose tafenoquine (10 mg/kg) given with fat - Pharmacokinetics of Tafenoquine
Phase 4RecruitingCurtin University302025-10-202026-03-18
Vivax Elimination With Tafenoquine (VET) Study
Tafenoquine - Malaria, Malaria, Vivax
Phase 4CompletedShoklo Malaria Research Unit12422025-02-192026-01-06
Southeast Asia Dose Optimization of Tafenoquine
Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg - Plasmodium Vivax Malaria
Phase 4RecruitingUniversity of Oxford8202024-07-222026-10-09
Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days, Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose). - Vivax Malaria, G6PD Deficiency
Phase 4RecruitingMenzies School of Health Research1002024-05-172026-03-12
Tafenoquine and Primaquine in Colostrum and Breast Milk
Primaquine, Tafenoquine - Healthy Lactating Women
Phase 4WithdrawnUniversity of Oxford2023-07-012024-04-04
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose), Chloroquine plus Tafenoquine (450 mg adult dose), Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose) - Malaria, Malaria, Vivax
Phase 4RecruitingShoklo Malaria Research Unit6062023-06-262025-05-16
Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax
Chloroquine, Primaquine - Efficacy, Malaria
Phase 4CompletedDinka Dugassa1002022-12-192023-09-22
Short Course Radical Cure of P. Vivax Malaria in Nepal
primaquine - Malaria, Malaria, Vivax
Phase 4CompletedMenzies School of Health Research272021-10-272024-08-29
Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure
Primaquine, Artesunate - Vivax Malaria
Phase 4CompletedUniversity of Maryland, Baltimore1602021-04-152026-06-03
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas
primaquine - Malaria, Vivax Malaria
Phase 4CompletedMenzies School of Health Research5002019-08-182023-11-21
Assessing a Risk Model for G6PD Deficiency
primaquine, chloroquine + primaquine - Malaria, Vivax, G6PD Deficiency
Phase 4TerminatedPATH542018-05-072021-11-12
G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Chloroquine, Primaquine 0.25 mg/kg/day, Primaquine 0.75 mg/kg weekly - Vivax Malaria
Phase 4CompletedUniversity of Oxford10002016-09-012020-10-14
Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam
Chloroquine - Plasmodium Vivax
Phase 4UnknownNational Institute of Malariology, Parasitology and Entomology, Vietnam1002015-03-012016-03-23
Assessment of Plasmodium Vivax Chloroquine Resistance in Cambodia:
Chloroquine sulfate, DHA-PP - Vivax Malaria
Phase 4CompletedInstitut Pasteur, Cambodia732014-05-012015-03-24
Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
Chloroquine, Dihydroartemisinin/Piperaquine - Plasmodium Vivax Malaria
Phase 4CompletedOxford University Clinical Research Unit, Vietnam3302013-02-012016-09-30
Ethiopia Antimalarial in Vivo Efficacy Study 2012
Artemether-lumefantrine combination, Primaquine, Chloroquine - Plasmodium Vivax Infection
Phase 4CompletedCenters for Disease Control and Prevention3982012-10-012017-01-19
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)
Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine - Plasmodium Vivax Malaria
Phase 4TerminatedCenters for Disease Control and Prevention162011-02-012012-04-13
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Primaquine - Plasmodium Vivax
Phase 4UnknownPapua New Guinea Institute of Medical Research1502010-06-012015-10-14

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Malaria (11)  ·  Malaria, Falciparum (3)  ·  Recurrence (3)  ·  Glucosephosphate Dehydrogenase Deficiency (2)

Broader conditions

Infections (24)  ·  Mosquito-Borne Diseases (24)  ·  Parasitic Diseases (24)  ·  Protozoan Infections (24)  ·  Vector Borne Diseases (24)  ·  Malaria (13)  ·  Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Anemia (2)  ·  Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)

Interventions

Primaquine (14)  ·  Chloroquine (13)  ·  tafenoquine (7)  ·  Artemether, Lumefantrine Drug Combination (5)  ·  artenimol (2)  ·  chloroquine diphosphate (2)  ·  piperaquine (2)  ·  2,6-diisopropylphenol docosahexaenoate (1)  ·  Artemether (1)  ·  Artesunate (1)  ·  CD36 Antigens (1)  ·  Lumefantrine (1)  ·  Water (1)  ·  lactitol (1)  ·  pyronaridine tetraphosphate, artesunate drug combination (1)

Sponsors

Menzies School of Health Research (4)  ·  University of Oxford (4)  ·  Centers for Disease Control and Prevention (2)  ·  Curtin University (2)  ·  Papua New Guinea Institute of Medical Research (2)  ·  Shoklo Malaria Research Unit (2)  ·  Dinka Dugassa (1)  ·  Institut Pasteur, Cambodia (1)  ·  Institut de Recherche pour le Developpement (1)  ·  LILIA GONZALEZ CERON (1)  ·  National Institute of Malariology, Parasitology and Entomology, Vietnam (1)  ·  Oxford University Clinical Research Unit, Vietnam (1)  ·  PATH (1)  ·  University of Maryland, Baltimore (1)

Countries

Papua New Guinea (5)  ·  Thailand (5)  ·  Ethiopia (4)  ·  Cambodia (3)  ·  Vietnam (3)  ·  Afghanistan (2)  ·  Brazil (2)  ·  Indonesia (2)  ·  Bangladesh (1)  ·  Laos (1)  ·  Nepal (1)

Top investigators

Brioni R Moore, PhD (2)  ·  Ivo Mueller, PhD (2)  ·  Anna Rosanas-Urgell, MD, PhD (1)  ·  Bockretsion Gidey (1)  ·  Cindy Chu, MD, PhD (1)  ·  David Hoos, MD MPH (1)  ·  Duong Tran, MD, PhD (1)  ·  Dysoley Lek, MD (1)  ·  Francois Nosten, Prof (1)  ·  Ghulam Rahim Awab, MD (1)  ·  Inoni Betuela, MD PhD (1)  ·  Inoni Betuela, MD, PhD (1)

Results publications

PMID 22531245, PMID 23212366, PMID 26505753, PMID 26518132, PMID 28510573, PMID 28732068, PMID 28862132, PMID 29362233, PMID 29398388, PMID 30698522, PMID 33299558, PMID 33552517, PMID 34031050, PMID 34336132, PMID 35585641, PMID 36099312, PMID 36534705, PMID 37269941, PMID 37790581, PMID 37979594, PMID 38115002, PMID 39802788, PMID 40112852, PMID 40764298, PMID 42033147, PMID 42439801

NIH funding

R01AI103228 (1)